The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it hold, with a mean price target of $627.
Lockheed Martin
LMT · a US exchange · USD · Market cap $123.7B · 123,000 employees
Lockheed Martin Corporation, an aerospace and defense company, engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services in the United States, E…
FAIL · Does not pass the screenAt the last full screen
2026-09-08
Screened 2026-09-08 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
Lockheed Martin holds its Distribution at $536.15. The statistical read favours the buyers, held for 22 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the buyers, held for 22 days |
| Price at the screen | $536.15 |
| Valuation | 19.78 trailing · 16.39 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.10 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Aerospace & Defense | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 19% discount to our $637.22 fair value, narrow competitive moat, 10.50% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. A 18.9% margin of safety to the base estimate.
Third-party analyst targets: 19 covering, consensus Hold. The average target sits +16% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsLockheed Martin - A Skewed Star in the Defense Sky
Imagine the world's largest defense contractor, Lockheed Martin, building the next generation of fighter jets and satellites, shaping the future of warfare. But while it stands as a titan in its field, ethical considerations cast a long shadow. Lockheed Martin is the epitome of the military-industrial complex, and it fails our ethical screen, which is why we're steering clear.
Why it stands out, or rather, why we pass, is not solely about finances. The numbers tell a story of growth with a 10% revenue increase and an impressive 89% return on equity, suggesting a robust business. The forward P/E of 17.5x and our fair value of $637.17 point to a potential undervaluation. However, the ethical failings overshadow these financials.
The risk here is twofold: the ethical considerations that lead to our AVOID rating and the cyclical nature of defense spending, which can trap investors at peak earnings into a low multiple value trap. While analysts may hold a consensus rating of 'hold' with a median target of $620, our ethical stance leaves us unable to align with such investments. Analysis, not advice.
| Forward P/E | 16.4xpriced for continued growth |
| Trailing P/E | 19.8xreasonably valued |
| EPS, trailing | 27.10 |
| EPS, forward | 32.72 |
| Revenue growth | +10.5%steady growth |
| Profit margin | 8.2%thin but positive margins |
| Return on equity | 89.2%an exceptional return on shareholder capital |
| FCF yield | 4.50% |
| Dividend yield | 267.00% |
| Debt to equity | 2.34heavy leverage: higher risk if revenue softens |
| Current ratio | 1.19adequate liquidity, worth monitoring |
| Beta | 0.10barely tracks the market's swings |
| Short interest, float | 0.01% |
| 52-week range | 437.25 - 692.00 |
| Moat | NARROW |
| Market cap | $123.7B |
| Employees | 123,000 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeLMT trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it hold, with a mean price target of $627. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it hold, with a mean price target of $627. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it hold, with a mean price target of $627. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it hold, with a mean price target of $627. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it hold, with a mean price target of $627. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 13%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (19 analysts) rates it hold, with a mean price target of $627. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Lockheed Martin's Missile Segment Could Grow 150% by 2030 GuruFocus.com · 10d ago
- Time to Buy the Dip on Defense Stocks? Barrons.com · 10d ago
- How Far Could RKLB Stock Fall In The Next Shock? Trefis · 10d ago
- Why Lockheed Martin Stock Popped Today Motley Fool · 10d ago
- Should You Buy GE Aerospace Stock On Cash That Came Early? Trefis · 10d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-01 | HOLLUB VICKI A. | Director | 415 | · | |
| 2026-03-11 | CAHILL TIMOTHY S | Officer | 4,620 | $3,000,551 | |
| 2026-02-27 | ULMER GREGORY M | Officer | 2,840 | $1,868,947 | |
| 2026-02-26 | O'CONNOR KEVIN J | General Counsel | 5,285 | · | |
| 2026-02-24 | HILL STEPHANIE C | Officer | 2,410 | $1,592,149 | |
| 2026-02-20 | TAICLET JAMES D JR | Chief Executive Officer | 7,842 | · | |
| 2026-02-20 | ST JOHN FRANK A | Chief Operating Officer | 3,063 | · | |
| 2026-02-20 | ULMER GREGORY M | Officer | 2,059 | · | |
| 2026-02-20 | LIGHTFOOT ROBERT M JR | Officer | 2,059 | · | |
| 2026-02-20 | PAUL HARRY EDWARD III | Officer | 209 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 7 Feb2025 | Tim Walberg | Republican | buy | 1K–15K |
| 27 Mar2026 | Alan Armstrong | Republican | buy | 1K–15K |
| 2024-07-20 | April McClain Delaney | buy | 8000 | |
| 2023-08-15 | Mark Green | buy | 20000 |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $508.92 | +3.3% | $3.45 | $1,040 | +4.0% |
| 2 months | $609.73 | -13.8% | $3.45 | $868 | -13.2% |
| 3 months | $648.58 | -18.9% | $3.45 | $816 | -18.4% |
| 6 months | $469.32 | +12.0% | $6.90 | $1,135 | +13.5% |
| 1 year | $464.38 | +13.2% | $13.65 | $1,161 | +16.1% |
| 2 years | $443.49 | +18.5% | $26.70 | $1,246 | +24.6% |
| 3 years | $426.93 | +23.1% | $39.15 | $1,323 | +32.3% |
| 5 years | $338.83 | +55.2% | $61.95 | $1,734 | +73.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever LMT does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.